OppenheimerFunds’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$230M Buy
1,443,145
+4,721
+0.3% +$684K 0.29% 91
2018
Q4
$138M Sell
1,438,424
-145,196
-9% -$16.6M 0.2% 122
2018
Q3
$224M Sell
1,583,620
-14,547
-0.9% -$2.25M 0.26% 103
2018
Q2
$250M Buy
1,598,167
+34,389
+2% +$5.4M 0.3% 89
2018
Q1
$252M Buy
1,563,778
+84,247
+6% +$14.3M 0.31% 84
2017
Q4
$244M Sell
1,479,531
-314,473
-18% -$30.5M 0.29% 87
2017
Q3
$112M Buy
1,794,004
+8,364
+0.5% +$657K 0.14% 170
2017
Q2
$142M Buy
1,785,640
+6,401
+0.4% +$463K 0.18% 148
2017
Q1
$126M Sell
1,779,239
-156,836
-8% -$9.19M 0.15% 166
2016
Q4
$98.9M Buy
1,936,075
+20,201
+1% +$952K 0.13% 194
2016
Q3
$88.2M Buy
1,915,874
+1,145,717
+149% +$46.6M 0.11% 216
2016
Q2
$23.2M Buy
770,157
+20,591
+3% +$687K 0.03% 515
2016
Q1
$24M Buy
+749,566
New +$26.4M 0.03% 505

Other funds holding SAGE